H. Lundbeck A/S (HLBBF)
OTCMKTS · Delayed Price · Currency is USD
6.85
-0.45 (-6.16%)
At close: Oct 31, 2025
H. Lundbeck Market Cap
H. Lundbeck has a market cap or net worth of $6.69 billion as of November 6, 2025. Its market cap has increased by 1.08% in one year.
Market Cap
6.69B
Enterprise Value
8.39B
Revenue
3.70B
Ranking
n/a
PE Ratio
12.20
Stock Price
$6.85
Market Cap Chart
Since June 10, 2022, H. Lundbeck's market cap has increased from 4.54B to 6.69B, an increase of 47.50%. That is a compound annual growth rate of 12.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 6.64B | 20.96% |
| Dec 30, 2024 | 5.49B | 16.62% |
| Dec 29, 2023 | 4.70B | 28.73% |
| Dec 30, 2022 | 3.65B | -19.48% |
| Jun 10, 2022 | 4.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 654.92M |
| Glass House Brands | 582.61M |
| Northwest Biotherapeutics | 386.96M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 311.61M |
| Silence Therapeutics | 307.49M |
| American Oncology Network | 307.04M |